866-997-4948(US-Canada Toll Free)

Global Drugs for Vulvovaginal Candidiasis Sales Market Report 2018

Published By :

QYResearch

Published Date : Jun 2018

Category :

Pharmaceutical

No. of Pages : 108 Pages

This report studies the global Drugs for Vulvovaginal Candidiasis market status and forecast, categorizes the global Drugs for Vulvovaginal Candidiasis market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cure rates in excess of 80%. The only oral azole agent approved for this indication by the US Food and Drug Administration (FDA) is fluconazole, which also achieves a high cure rate. Therapeutic concentrations are found in vaginal secretions for at least 72 hours after the ingestion of a single 150-mg tablet.

Some women with recurrent candidal infections opt for treatment with over-the-counter (OTC) medications, which generally are highly effective for candidiasis. Preparations for intravaginal administration of butoconazole, clotrimazole, miconazole, and tioconazole are available OTC.
The classification of Drugs for Vulvovaginal Candidiasis includes Cream, Pessary and other. The proportion of Cream in 2017 is about 47.2%, and the proportion of Pessary in 2017 is about 34.1%.
The drugs for Vulvovaginal Candidiasis are Miconazole, Clotrimazole, Fluconazole, Econazole and Other, market share of Fluconazole is about 24.5% in 2017.
Drugs for Vulvovaginal Candidiasis is application in Hospital & Clinic and Pharmacy. The most of Drugs for Vulvovaginal Candidiasis is used in Pharmacy, and the market share in 2016 is about 59%.
The global Drugs for Vulvovaginal Candidiasis market is valued at 770 million US$ in 2017 and will reach 860 million US$ by the end of 2025, growing at a CAGR of 1.5% during 2018-2025.

The major players covered in this report
Bayer
Perrigo
J & J
Pfizer
Bristol-Myers Squibb
Effik
Teva
Sanofi
Cisen Pharmaceutical
Kingyork Group

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
By Formulation Types
Cream
Pessary
Other
By Drugs Types
Miconazole
Clotrimazole
Fluconazole
Econazole
Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospital & Clinic
Pharmacy

The study objectives of this report are:
To analyze and study the global Drugs for Vulvovaginal Candidiasis sales, value, status (2013-2017) and forecast (2018-2025);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Drugs for Vulvovaginal Candidiasis players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Drugs for Vulvovaginal Candidiasis are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Drugs for Vulvovaginal Candidiasis Manufacturers
Drugs for Vulvovaginal Candidiasis Distributors/Traders/Wholesalers
Drugs for Vulvovaginal Candidiasis Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Drugs for Vulvovaginal Candidiasis market, by end-use.
Detailed analysis and profiles of additional market players.
Table of Contents

Global Drugs for Vulvovaginal Candidiasis Sales Market Report 2018
1 Drugs for Vulvovaginal Candidiasis Market Overview
1.1 Product Overview and Scope of Drugs for Vulvovaginal Candidiasis
1.2 Classification of Drugs for Vulvovaginal Candidiasis by Product Category
1.2.1 Global Drugs for Vulvovaginal Candidiasis Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Drugs for Vulvovaginal Candidiasis Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Cream
1.2.4 Pessary
1.2.5 Other
1.3 Global Drugs for Vulvovaginal Candidiasis Market by Application/End Users
1.3.1 Global Drugs for Vulvovaginal Candidiasis Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.1 Hospital & Clinic
1.3.2 Pharmacy
1.4 Global Drugs for Vulvovaginal Candidiasis Market by Region
1.4.1 Global Drugs for Vulvovaginal Candidiasis Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Drugs for Vulvovaginal Candidiasis Status and Prospect (2013-2025)
1.4.3 Europe Drugs for Vulvovaginal Candidiasis Status and Prospect (2013-2025)
1.4.4 China Drugs for Vulvovaginal Candidiasis Status and Prospect (2013-2025)
1.4.5 Japan Drugs for Vulvovaginal Candidiasis Status and Prospect (2013-2025)
1.4.6 Southeast Asia Drugs for Vulvovaginal Candidiasis Status and Prospect (2013-2025)
1.4.7 India Drugs for Vulvovaginal Candidiasis Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Drugs for Vulvovaginal Candidiasis (2013-2025)
1.5.1 Global Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2025)
1.5.2 Global Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate (2013-2025)

2 Global Drugs for Vulvovaginal Candidiasis Competition by Players/Suppliers, Type and Application
2.1 Global Drugs for Vulvovaginal Candidiasis Market Competition by Players/Suppliers
2.1.1 Global Drugs for Vulvovaginal Candidiasis Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Drugs for Vulvovaginal Candidiasis Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Drugs for Vulvovaginal Candidiasis (Volume and Value) by Type
2.2.1 Global Drugs for Vulvovaginal Candidiasis Sales and Market Share by Type (2013-2018)
2.2.2 Global Drugs for Vulvovaginal Candidiasis Revenue and Market Share by Type (2013-2018)
2.3 Global Drugs for Vulvovaginal Candidiasis (Volume and Value) by Region
2.3.1 Global Drugs for Vulvovaginal Candidiasis Sales and Market Share by Region (2013-2018)
2.3.2 Global Drugs for Vulvovaginal Candidiasis Revenue and Market Share by Region (2013-2018)
2.4 Global Drugs for Vulvovaginal Candidiasis (Volume) by Application

3 United States Drugs for Vulvovaginal Candidiasis (Volume, Value and Sales Price)
3.1 United States Drugs for Vulvovaginal Candidiasis Sales and Value (2013-2018)
3.1.1 United States Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
3.1.2 United States Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate (2013-2018)
3.1.3 United States Drugs for Vulvovaginal Candidiasis Sales Price Trend (2013-2018)
3.2 United States Drugs for Vulvovaginal Candidiasis Sales Volume and Market Share by Players (2013-2018)
3.3 United States Drugs for Vulvovaginal Candidiasis Sales Volume and Market Share by Type (2013-2018)
3.4 United States Drugs for Vulvovaginal Candidiasis Sales Volume and Market Share by Application (2013-2018)

4 Europe Drugs for Vulvovaginal Candidiasis (Volume, Value and Sales Price)
4.1 Europe Drugs for Vulvovaginal Candidiasis Sales and Value (2013-2018)
4.1.1 Europe Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
4.1.2 Europe Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate (2013-2018)
4.1.3 Europe Drugs for Vulvovaginal Candidiasis Sales Price Trend (2013-2018)
4.2 Europe Drugs for Vulvovaginal Candidiasis Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Drugs for Vulvovaginal Candidiasis Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Drugs for Vulvovaginal Candidiasis Sales Volume and Market Share by Application (2013-2018)

5 China Drugs for Vulvovaginal Candidiasis (Volume, Value and Sales Price)
5.1 China Drugs for Vulvovaginal Candidiasis Sales and Value (2013-2018)
5.1.1 China Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
5.1.2 China Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate (2013-2018)
5.1.3 China Drugs for Vulvovaginal Candidiasis Sales Price Trend (2013-2018)
5.2 China Drugs for Vulvovaginal Candidiasis Sales Volume and Market Share by Players (2013-2018)
5.3 China Drugs for Vulvovaginal Candidiasis Sales Volume and Market Share by Type (2013-2018)
5.4 China Drugs for Vulvovaginal Candidiasis Sales Volume and Market Share by Application (2013-2018)

6 Japan Drugs for Vulvovaginal Candidiasis (Volume, Value and Sales Price)
6.1 Japan Drugs for Vulvovaginal Candidiasis Sales and Value (2013-2018)
6.1.1 Japan Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
6.1.2 Japan Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate (2013-2018)
6.1.3 Japan Drugs for Vulvovaginal Candidiasis Sales Price Trend (2013-2018)
6.2 Japan Drugs for Vulvovaginal Candidiasis Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Drugs for Vulvovaginal Candidiasis Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Drugs for Vulvovaginal Candidiasis Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Drugs for Vulvovaginal Candidiasis (Volume, Value and Sales Price)
7.1 Southeast Asia Drugs for Vulvovaginal Candidiasis Sales and Value (2013-2018)
7.1.1 Southeast Asia Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Drugs for Vulvovaginal Candidiasis Sales Price Trend (2013-2018)
7.2 Southeast Asia Drugs for Vulvovaginal Candidiasis Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Drugs for Vulvovaginal Candidiasis Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Drugs for Vulvovaginal Candidiasis Sales Volume and Market Share by Application (2013-2018)

8 India Drugs for Vulvovaginal Candidiasis (Volume, Value and Sales Price)
8.1 India Drugs for Vulvovaginal Candidiasis Sales and Value (2013-2018)
8.1.1 India Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2013-2018)
8.1.2 India Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate (2013-2018)
8.1.3 India Drugs for Vulvovaginal Candidiasis Sales Price Trend (2013-2018)
8.2 India Drugs for Vulvovaginal Candidiasis Sales Volume and Market Share by Players (2013-2018)
8.3 India Drugs for Vulvovaginal Candidiasis Sales Volume and Market Share by Type (2013-2018)
8.4 India Drugs for Vulvovaginal Candidiasis Sales Volume and Market Share by Application (2013-2018)

9 Global Drugs for Vulvovaginal Candidiasis Players/Suppliers Profiles and Sales Data
9.1 Bayer
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Drugs for Vulvovaginal Candidiasis Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Bayer Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 Perrigo
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Drugs for Vulvovaginal Candidiasis Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Perrigo Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 J & J
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Drugs for Vulvovaginal Candidiasis Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 J & J Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview
9.4 Pfizer
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Drugs for Vulvovaginal Candidiasis Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Pfizer Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2013-2018)
9.4.4 Main Business/Business Overview
9.5 Bristol-Myers Squibb
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Drugs for Vulvovaginal Candidiasis Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Bristol-Myers Squibb Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2013-2018)
9.5.4 Main Business/Business Overview
9.6 Effik
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Drugs for Vulvovaginal Candidiasis Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Effik Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2013-2018)
9.6.4 Main Business/Business Overview
9.7 Teva
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Drugs for Vulvovaginal Candidiasis Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Teva Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2013-2018)
9.7.4 Main Business/Business Overview
9.8 Sanofi
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Drugs for Vulvovaginal Candidiasis Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Sanofi Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2013-2018)
9.8.4 Main Business/Business Overview
9.9 Cisen Pharmaceutical
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Drugs for Vulvovaginal Candidiasis Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Cisen Pharmaceutical Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2013-2018)
9.9.4 Main Business/Business Overview
9.10 Kingyork Group
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Drugs for Vulvovaginal Candidiasis Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Kingyork Group Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2013-2018)
9.10.4 Main Business/Business Overview

10 Drugs for Vulvovaginal Candidiasis Maufacturing Cost Analysis
10.1 Drugs for Vulvovaginal Candidiasis Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Drugs for Vulvovaginal Candidiasis
10.3 Manufacturing Process Analysis of Drugs for Vulvovaginal Candidiasis

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Drugs for Vulvovaginal Candidiasis Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Drugs for Vulvovaginal Candidiasis Major Manufacturers in 2017
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Drugs for Vulvovaginal Candidiasis Market Forecast (2018-2025)
14.1 Global Drugs for Vulvovaginal Candidiasis Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Drugs for Vulvovaginal Candidiasis Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Drugs for Vulvovaginal Candidiasis Price and Trend Forecast (2018-2025)
14.2 Global Drugs for Vulvovaginal Candidiasis Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Drugs for Vulvovaginal Candidiasis Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Drugs for Vulvovaginal Candidiasis Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Drugs for Vulvovaginal Candidiasis Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Drugs for Vulvovaginal Candidiasis Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Drugs for Vulvovaginal Candidiasis Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Drugs for Vulvovaginal Candidiasis Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Drugs for Vulvovaginal Candidiasis Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Drugs for Vulvovaginal Candidiasis Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Drugs for Vulvovaginal Candidiasis Sales Forecast by Type (2018-2025)
14.3.2 Global Drugs for Vulvovaginal Candidiasis Revenue Forecast by Type (2018-2025)
14.3.3 Global Drugs for Vulvovaginal Candidiasis Price Forecast by Type (2018-2025)
14.4 Global Drugs for Vulvovaginal Candidiasis Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Table

List of Tables and Figures

Figure Product Picture of Drugs for Vulvovaginal Candidiasis
Figure Global Drugs for Vulvovaginal Candidiasis Sales Volume Comparison (K Units) by Type (2013-2025)
Figure Global Drugs for Vulvovaginal Candidiasis Sales Volume Market Share by Type (Product Category) in 2017
Figure Cream Product Picture
Figure Pessary Product Picture
Figure Other Product Picture
Figure Global Drugs for Vulvovaginal Candidiasis Sales Comparison (K Units) by Application (2013-2025)
Figure Global Sales Market Share of Drugs for Vulvovaginal Candidiasis by Application in 2017
Figure Hospital & Clinic Examples
Table Key Downstream Customer in Hospital & Clinic
Figure Pharmacy Examples
Table Key Downstream Customer in Pharmacy
Figure Global Drugs for Vulvovaginal Candidiasis Market Size (Million USD) by Regions (2013-2025)
Figure United States Drugs for Vulvovaginal Candidiasis Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Drugs for Vulvovaginal Candidiasis Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Drugs for Vulvovaginal Candidiasis Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Drugs for Vulvovaginal Candidiasis Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Drugs for Vulvovaginal Candidiasis Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Drugs for Vulvovaginal Candidiasis Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Drugs for Vulvovaginal Candidiasis Sales Volume (K Units) and Growth Rate (2013-2025)
Figure Global Drugs for Vulvovaginal Candidiasis Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Drugs for Vulvovaginal Candidiasis Sales Volume (K Units) (2013-2018)
Table Global Drugs for Vulvovaginal Candidiasis Sales (K Units) of Key Players/Suppliers (2013-2018)
Table Global Drugs for Vulvovaginal Candidiasis Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Drugs for Vulvovaginal Candidiasis Sales Share by Players/Suppliers
Figure 2017 Drugs for Vulvovaginal Candidiasis Sales Share by Players/Suppliers
Figure Global Drugs for Vulvovaginal Candidiasis Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Drugs for Vulvovaginal Candidiasis Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Drugs for Vulvovaginal Candidiasis Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Drugs for Vulvovaginal Candidiasis Revenue Share by Players
Table 2017 Global Drugs for Vulvovaginal Candidiasis Revenue Share by Players
Table Global Drugs for Vulvovaginal Candidiasis Sales (K Units) and Market Share by Type (2013-2018)
Table Global Drugs for Vulvovaginal Candidiasis Sales Share (K Units) by Type (2013-2018)
Figure Sales Market Share of Drugs for Vulvovaginal Candidiasis by Type (2013-2018)
Figure Global Drugs for Vulvovaginal Candidiasis Sales Growth Rate by Type (2013-2018)
Table Global Drugs for Vulvovaginal Candidiasis Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Drugs for Vulvovaginal Candidiasis Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Drugs for Vulvovaginal Candidiasis by Type (2013-2018)
Figure Global Drugs for Vulvovaginal Candidiasis Revenue Growth Rate by Type (2013-2018)
Table Global Drugs for Vulvovaginal Candidiasis Sales Volume (K Units) and Market Share by Region (2013-2018)
Table Global Drugs for Vulvovaginal Candidiasis Sales Share by Region (2013-2018)
Figure Sales Market Share of Drugs for Vulvovaginal Candidiasis by Region (2013-2018)
Figure Global Drugs for Vulvovaginal Candidiasis Sales Growth Rate by Region in 2017
Table Global Drugs for Vulvovaginal Candidiasis Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Drugs for Vulvovaginal Candidiasis Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Drugs for Vulvovaginal Candidiasis by Region (2013-2018)
Figure Global Drugs for Vulvovaginal Candidiasis Revenue Growth Rate by Region in 2017
Table Global Drugs for Vulvovaginal Candidiasis Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Drugs for Vulvovaginal Candidiasis Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Drugs for Vulvovaginal Candidiasis by Region (2013-2018)
Figure Global Drugs for Vulvovaginal Candidiasis Revenue Market Share by Region in 2017
Table Global Drugs for Vulvovaginal Candidiasis Sales Volume (K Units) and Market Share by Application (2013-2018)
Table Global Drugs for Vulvovaginal Candidiasis Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Drugs for Vulvovaginal Candidiasis by Application (2013-2018)
Figure Global Drugs for Vulvovaginal Candidiasis Sales Market Share by Application (2013-2018)
Figure United States Drugs for Vulvovaginal Candidiasis Sales (K Units) and Growth Rate (2013-2018)
Figure United States Drugs for Vulvovaginal Candidiasis Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Drugs for Vulvovaginal Candidiasis Sales Price (USD/Unit) Trend (2013-2018)
Table United States Drugs for Vulvovaginal Candidiasis Sales Volume (K Units) by Players (2013-2018)
Table United States Drugs for Vulvovaginal Candidiasis Sales Volume Market Share by Players (2013-2018)
Figure United States Drugs for Vulvovaginal Candidiasis Sales Volume Market Share by Players in 2017
Table United States Drugs for Vulvovaginal Candidiasis Sales Volume (K Units) by Type (2013-2018)
Table United States Drugs for Vulvovaginal Candidiasis Sales Volume Market Share by Type (2013-2018)
Figure United States Drugs for Vulvovaginal Candidiasis Sales Volume Market Share by Type in 2017
Table United States Drugs for Vulvovaginal Candidiasis Sales Volume (K Units) by Application (2013-2018)
Table United States Drugs for Vulvovaginal Candidiasis Sales Volume Market Share by Application (2013-2018)
Figure United States Drugs for Vulvovaginal Candidiasis Sales Volume Market Share by Application in 2017
Figure Europe Drugs for Vulvovaginal Candidiasis Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Drugs for Vulvovaginal Candidiasis Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Drugs for Vulvovaginal Candidiasis Sales Price (USD/Unit) Trend (2013-2018)
Table Europe Drugs for Vulvovaginal Candidiasis Sales Volume (K Units) by Players (2013-2018)
Table Europe Drugs for Vulvovaginal Candidiasis Sales Volume Market Share by Players (2013-2018)
Figure Europe Drugs for Vulvovaginal Candidiasis Sales Volume Market Share by Players in 2017
Table Europe Drugs for Vulvovaginal Candidiasis Sales Volume (K Units) by Type (2013-2018)
Table Europe Drugs for Vulvovaginal Candidiasis Sales Volume Market Share by Type (2013-2018)
Figure Europe Drugs for Vulvovaginal Candidiasis Sales Volume Market Share by Type in 2017
Table Europe Drugs for Vulvovaginal Candidiasis Sales Volume (K Units) by Application (2013-2018)
Table Europe Drugs for Vulvovaginal Candidiasis Sales Volume Market Share by Application (2013-2018)
Figure Europe Drugs for Vulvovaginal Candidiasis Sales Volume Market Share by Application in 2017
Figure China Drugs for Vulvovaginal Candidiasis Sales (K Units) and Growth Rate (2013-2018)
Figure China Drugs for Vulvovaginal Candidiasis Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Drugs for Vulvovaginal Candidiasis Sales Price (USD/Unit) Trend (2013-2018)
Table China Drugs for Vulvovaginal Candidiasis Sales Volume (K Units) by Players (2013-2018)
Table China Drugs for Vulvovaginal Candidiasis Sales Volume Market Share by Players (2013-2018)
Figure China Drugs for Vulvovaginal Candidiasis Sales Volume Market Share by Players in 2017
Table China Drugs for Vulvovaginal Candidiasis Sales Volume (K Units) by Type (2013-2018)
Table China Drugs for Vulvovaginal Candidiasis Sales Volume Market Share by Type (2013-2018)
Figure China Drugs for Vulvovaginal Candidiasis Sales Volume Market Share by Type in 2017
Table China Drugs for Vulvovaginal Candidiasis Sales Volume (K Units) by Application (2013-2018)
Table China Drugs for Vulvovaginal Candidiasis Sales Volume Market Share by Application (2013-2018)
Figure China Drugs for Vulvovaginal Candidiasis Sales Volume Market Share by Application in 2017
Figure Japan Drugs for Vulvovaginal Candidiasis Sales (K Units) and Growth Rate (2013-2018)
Figure Japan Drugs for Vulvovaginal Candidiasis Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Drugs for Vulvovaginal Candidiasis Sales Price (USD/Unit) Trend (2013-2018)
Table Japan Drugs for Vulvovaginal Candidiasis Sales Volume (K Units) by Players (2013-2018)
Table Japan Drugs for Vulvovaginal Candidiasis Sales Volume Market Share by Players (2013-2018)
Figure Japan Drugs for Vulvovaginal Candidiasis Sales Volume Market Share by Players in 2017
Table Japan Drugs for Vulvovaginal Candidiasis Sales Volume (K Units) by Type (2013-2018)
Table Japan Drugs for Vulvovaginal Candidiasis Sales Volume Market Share by Type (2013-2018)
Figure Japan Drugs for Vulvovaginal Candidiasis Sales Volume Market Share by Type in 2017
Table Japan Drugs for Vulvovaginal Candidiasis Sales Volume (K Units) by Application (2013-2018)
Table Japan Drugs for Vulvovaginal Candidiasis Sales Volume Market Share by Application (2013-2018)
Figure Japan Drugs for Vulvovaginal Candidiasis Sales Volume Market Share by Application in 2017
Figure Southeast Asia Drugs for Vulvovaginal Candidiasis Sales (K Units) and Growth Rate (2013-2018)
Figure Southeast Asia Drugs for Vulvovaginal Candidiasis Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Drugs for Vulvovaginal Candidiasis Sales Price (USD/Unit) Trend (2013-2018)
Table Southeast Asia Drugs for Vulvovaginal Candidiasis Sales Volume (K Units) by Players (2013-2018)
Table Southeast Asia Drugs for Vulvovaginal Candidiasis Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Drugs for Vulvovaginal Candidiasis Sales Volume Market Share by Players in 2017
Table Southeast Asia Drugs for Vulvovaginal Candidiasis Sales Volume (K Units) by Type (2013-2018)
Table Southeast Asia Drugs for Vulvovaginal Candidiasis Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Drugs for Vulvovaginal Candidiasis Sales Volume Market Share by Type in 2017
Table Southeast Asia Drugs for Vulvovaginal Candidiasis Sales Volume (K Units) by Application (2013-2018)
Table Southeast Asia Drugs for Vulvovaginal Candidiasis Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Drugs for Vulvovaginal Candidiasis Sales Volume Market Share by Application in 2017
Figure India Drugs for Vulvovaginal Candidiasis Sales (K Units) and Growth Rate (2013-2018)
Figure India Drugs for Vulvovaginal Candidiasis Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Drugs for Vulvovaginal Candidiasis Sales Price (USD/Unit) Trend (2013-2018)
Table India Drugs for Vulvovaginal Candidiasis Sales Volume (K Units) by Players (2013-2018)
Table India Drugs for Vulvovaginal Candidiasis Sales Volume Market Share by Players (2013-2018)
Figure India Drugs for Vulvovaginal Candidiasis Sales Volume Market Share by Players in 2017
Table India Drugs for Vulvovaginal Candidiasis Sales Volume (K Units) by Type (2013-2018)
Table India Drugs for Vulvovaginal Candidiasis Sales Volume Market Share by Type (2013-2018)
Figure India Drugs for Vulvovaginal Candidiasis Sales Volume Market Share by Type in 2017
Table India Drugs for Vulvovaginal Candidiasis Sales Volume (K Units) by Application (2013-2018)
Table India Drugs for Vulvovaginal Candidiasis Sales Volume Market Share by Application (2013-2018)
Figure India Drugs for Vulvovaginal Candidiasis Sales Volume Market Share by Application in 2017
Table Bayer Basic Information List
Table Bayer Drugs for Vulvovaginal Candidiasis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bayer Drugs for Vulvovaginal Candidiasis Sales Growth Rate (2013-2018)
Figure Bayer Drugs for Vulvovaginal Candidiasis Sales Global Market Share (2013-2018)
Figure Bayer Drugs for Vulvovaginal Candidiasis Revenue Global Market Share (2013-2018)
Table Perrigo Basic Information List
Table Perrigo Drugs for Vulvovaginal Candidiasis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Perrigo Drugs for Vulvovaginal Candidiasis Sales Growth Rate (2013-2018)
Figure Perrigo Drugs for Vulvovaginal Candidiasis Sales Global Market Share (2013-2018)
Figure Perrigo Drugs for Vulvovaginal Candidiasis Revenue Global Market Share (2013-2018)
Table J & J Basic Information List
Table J & J Drugs for Vulvovaginal Candidiasis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure J & J Drugs for Vulvovaginal Candidiasis Sales Growth Rate (2013-2018)
Figure J & J Drugs for Vulvovaginal Candidiasis Sales Global Market Share (2013-2018
Figure J & J Drugs for Vulvovaginal Candidiasis Revenue Global Market Share (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Drugs for Vulvovaginal Candidiasis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Drugs for Vulvovaginal Candidiasis Sales Growth Rate (2013-2018)
Figure Pfizer Drugs for Vulvovaginal Candidiasis Sales Global Market Share (2013-2018)
Figure Pfizer Drugs for Vulvovaginal Candidiasis Revenue Global Market Share (2013-2018)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Drugs for Vulvovaginal Candidiasis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bristol-Myers Squibb Drugs for Vulvovaginal Candidiasis Sales Growth Rate (2013-2018)
Figure Bristol-Myers Squibb Drugs for Vulvovaginal Candidiasis Sales Global Market Share (2013-2018)
Figure Bristol-Myers Squibb Drugs for Vulvovaginal Candidiasis Revenue Global Market Share (2013-2018)
Table Effik Basic Information List
Table Effik Drugs for Vulvovaginal Candidiasis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Effik Drugs for Vulvovaginal Candidiasis Sales Growth Rate (2013-2018)
Figure Effik Drugs for Vulvovaginal Candidiasis Sales Global Market Share (2013-2018
Figure Effik Drugs for Vulvovaginal Candidiasis Revenue Global Market Share (2013-2018)
Table Teva Basic Information List
Table Teva Drugs for Vulvovaginal Candidiasis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Teva Drugs for Vulvovaginal Candidiasis Sales Growth Rate (2013-2018)
Figure Teva Drugs for Vulvovaginal Candidiasis Sales Global Market Share (2013-2018)
Figure Teva Drugs for Vulvovaginal Candidiasis Revenue Global Market Share (2013-2018)
Table Sanofi Basic Information List
Table Sanofi Drugs for Vulvovaginal Candidiasis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sanofi Drugs for Vulvovaginal Candidiasis Sales Growth Rate (2013-2018)
Figure Sanofi Drugs for Vulvovaginal Candidiasis Sales Global Market Share (2013-2018
Figure Sanofi Drugs for Vulvovaginal Candidiasis Revenue Global Market Share (2013-2018)
Table Cisen Pharmaceutical Basic Information List
Table Cisen Pharmaceutical Drugs for Vulvovaginal Candidiasis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Cisen Pharmaceutical Drugs for Vulvovaginal Candidiasis Sales Growth Rate (2013-2018)
Figure Cisen Pharmaceutical Drugs for Vulvovaginal Candidiasis Sales Global Market Share (2013-2018)
Figure Cisen Pharmaceutical Drugs for Vulvovaginal Candidiasis Revenue Global Market Share (2013-2018)
Table Kingyork Group Basic Information List
Table Kingyork Group Drugs for Vulvovaginal Candidiasis Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Kingyork Group Drugs for Vulvovaginal Candidiasis Sales Growth Rate (2013-2018)
Figure Kingyork Group Drugs for Vulvovaginal Candidiasis Sales Global Market Share (2013-2018)
Figure Kingyork Group Drugs for Vulvovaginal Candidiasis Revenue Global Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drugs for Vulvovaginal Candidiasis
Figure Manufacturing Process Analysis of Drugs for Vulvovaginal Candidiasis
Figure Drugs for Vulvovaginal Candidiasis Industrial Chain Analysis
Table Raw Materials Sources of Drugs for Vulvovaginal Candidiasis Major Players in 2017
Table Major Buyers of Drugs for Vulvovaginal Candidiasis
Table Distributors/Traders List
Figure Global Drugs for Vulvovaginal Candidiasis Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Drugs for Vulvovaginal Candidiasis Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Drugs for Vulvovaginal Candidiasis Price (USD/Unit) and Trend Forecast (2018-2025)
Table Global Drugs for Vulvovaginal Candidiasis Sales Volume (K Units) Forecast by Regions (2018-2025)
Figure Global Drugs for Vulvovaginal Candidiasis Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Drugs for Vulvovaginal Candidiasis Sales Volume Market Share Forecast by Regions in 2025
Table Global Drugs for Vulvovaginal Candidiasis Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Drugs for Vulvovaginal Candidiasis Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Drugs for Vulvovaginal Candidiasis Revenue Market Share Forecast by Regions in 2025
Figure United States Drugs for Vulvovaginal Candidiasis Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Drugs for Vulvovaginal Candidiasis Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Drugs for Vulvovaginal Candidiasis Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate Forecast (2018-2025)
Figure China Drugs for Vulvovaginal Candidiasis Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure China Drugs for Vulvovaginal Candidiasis Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Drugs for Vulvovaginal Candidiasis Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Drugs for Vulvovaginal Candidiasis Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Drugs for Vulvovaginal Candidiasis Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Drugs for Vulvovaginal Candidiasis Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Drugs for Vulvovaginal Candidiasis Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure India Drugs for Vulvovaginal Candidiasis Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Drugs for Vulvovaginal Candidiasis Sales (K Units) Forecast by Type (2018-2025)
Figure Global Drugs for Vulvovaginal Candidiasis Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Drugs for Vulvovaginal Candidiasis Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Drugs for Vulvovaginal Candidiasis Revenue Market Share Forecast by Type (2018-2025)
Table Global Drugs for Vulvovaginal Candidiasis Price (USD/Unit) Forecast by Type (2018-2025)
Table Global Drugs for Vulvovaginal Candidiasis Sales (K Units) Forecast by Application (2018-2025)
Figure Global Drugs for Vulvovaginal Candidiasis Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *